BLUEJET · Healthcare
The board meets on 5 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹181 cr | ₹167 cr | ₹184 cr | ₹163 cr | ₹208 cr | ₹318 cr | ₹340 cr | ₹355 cr | ₹165 cr | ₹192 cr | ₹235 cr | ₹293 cr |
| YoY | — | — | — | −9% | +15% | +90% | +85% | +118% | −21% | −40% | −31% | −17% |
| EBITDA margin | 34.8% | 32.9% | 28.8% | 27.0% | 33.2% | 39.0% | 41.2% | 34.1% | 33.3% | 24.5% | 30.2% | 33.4% |
| Other income, % of PBT | 13% | −7% | 17% | 18% | 16% | 10% | 8% | 7% | 35% | 24% | 26% | 14% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 26% | 27% | 27% | 24% | 24% | 25% | 25% | 26% | 24% | 25% | 26% | 26% |
| Net profit | ₹48.0 cr | ₹32.0 cr | ₹40.0 cr | ₹38.0 cr | ₹58.0 cr | ₹99.0 cr | ₹110 cr | ₹91.0 cr | ₹52.0 cr | ₹40.0 cr | ₹64.0 cr | ₹78.0 cr |
| YoY | — | — | — | −14% | +21% | +209% | +175% | +139% | −10% | −60% | −42% | −14% |
| Core profit YoY | — | — | — | −25% | +16% | +153% | +200% | +188% | −31% | −66% | −53% | −21% |
| EPS | ₹2.76 | ₹1.85 | ₹2.29 | ₹2.18 | ₹3.36 | ₹5.71 | ₹6.35 | ₹5.26 | ₹3.01 | ₹2.32 | ₹3.71 | ₹4.51 |
| Flags | · | · | · | 1 | 1 | 2 | 1 | ✓ | 1 | 1 | 1 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.